The California Institute for Regenerative Medicine has awarded a pair of $1.8 million grants to two UC Davis scientists to develop better tools for enabling physicians to assess the safety and efficacy of bioengineered tissues used to treat cardiovascular disease and bone and cartilage repair. Laura Marcu, a professor of biomedical engineering and neurological surgery, and her colleagues, aim to combine label-free optical and ultrasonic imaging technologies so that newly developed vascular replacement materials - typically used in surgical grafts to restore blood flow - can be better assessed and monitored directly in patients and thus prevent a graft's potential failure.
http://ift.tt/17mpW1g
http://ift.tt/17mpW1g
No comments:
Post a Comment